Blue–yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users

Autor: Katrin H. Preller, Michael Wagner, Lea M. Hulka, Daniela Jenni, Boris B. Quednow
Přispěvatelé: University of Zurich, Quednow, Boris B
Rok vydání: 2013
Předmět:
Adult
medicine.medical_specialty
Adolescent
genetic structures
N-Methyl-3
4-methylenedioxyamphetamine

medicine.medical_treatment
Amphetamine-Related Disorders
Ecstasy
Color Vision Defects
610 Medicine & health
Neuropsychological Tests
Audiology
Verbal learning
Cocaine-Related Disorders
Young Adult
2738 Psychiatry and Mental Health
03 medical and health sciences
0302 clinical medicine
U6 Integrative Human Physiology
medicine
Humans
2736 Pharmacology (medical)
Pharmacology (medical)
Effects of sleep deprivation on cognitive performance
10064 Neuroscience Center Zurich
Psychiatry
Amphetamine
Pharmacology
Working memory
Cortical blindness
Vision Tests
MDMA
Middle Aged
medicine.disease
030227 psychiatry
Stimulant
Psychiatry and Mental health
3004 Pharmacology
10054 Clinic for Psychiatry
Psychotherapy
and Psychosomatics

570 Life sciences
biology
Central Nervous System Stimulants
Cognition Disorders
Psychology
030217 neurology & neurosurgery
medicine.drug
Zdroj: The International Journal of Neuropsychopharmacology
The international journal of neuropsychopharmacology / official scientific journal of the Collegium
Popis: Specific blue–yellow colour vision impairment has been reported in dependent cocaine users and it was postulated that drug-induced changes in retinal dopamine neurotransmission are responsible. However, it is unclear whether these changes are confined to chronic cocaine users, whether they are specific for dopaminergic stimulants such as cocaine and amphetamine and whether they are related to cognitive functions such as working memory, encoding and consolidation. In 47 occasional and 29 dependent cocaine users, 23 MDMA (commonly known as ‘ecstasy’) users and 47 stimulant-naive controls, colour vision discrimination was measured with the Lanthony Desaturated Panel D-15 Test and memory performance with the Auditory Verbal Learning Test. Both occasional and dependent cocaine users showed higher colour confusion indices than controls. Users of the serotonergic stimulant MDMA (26%), occasional (30%) and dependent cocaine users (34%) exhibited more frequent blue–yellow colour vision disorders compared to controls (9%). Inferior performance of MDMA users was caused by a subgroup with high amphetamine co-use (55%), while MDMA use alone was not associated with decreased blue–yellow discrimination (0%). Cognitive performance was worse in cocaine users with colour vision disorder compared to users and controls with intact colour vision and both colour vision impairment and cognitive deficits were related to cocaine use. Occasional cocaine and amphetamine use might induce blue–yellow colour vision impairment, whereas the serotonergic stimulant MDMA does not impair colour vision. The association between colour vision impairment and cognitive deficits in cocaine users may reflect that retinal and cerebral dopamine alterations are linked to a certain degree.
Databáze: OpenAIRE